Form 8-K - Current report:
SEC Accession No. 0001493152-26-022721
Filing Date
2026-05-13
Accepted
2026-05-13 16:10:20
Documents
12
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 36943
2 EX-99.1 ex99-1.htm EX-99.1 143486
  Complete submission text file 0001493152-26-022721.txt   365834

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE imdx-20260513.xsd EX-101.SCH 3011
4 XBRL LABEL FILE imdx-20260513_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE imdx-20260513_pre.xml EX-101.PRE 22356
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3216
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 26973340
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)